A government and industry primary growth partnership aims to increase the annual value of New Zealand's manuka honey industry to $1.2 billion by 2028. Investment is going into product development and extracting more volume from manuka. The industry has limited competition, given the species only grows naturally in New Zealand and Australia.
However, it faces challenges around what constitutes manuka honey amid concerns about counterfeiting and consumer confusion.
Australia was the largest market for New Zealand honey last year, taking $48.6 million of product. That was followed by the UK ($46 million), China ($45.3 million), Hong Kong ($34.8 million), the US ($26.3 million) and Singapore ($20 million).
The export statistics cover natural honey, and exclude the use of manuka honey as an additive in health and nutritional products and medical-graded product used for wound treatment, which attracts a higher value.
Demand for manuka honey products has helped underpin sales for Comvita, the listed manuka honey and health products maker. Its share price has surged 132 per cent the past year, making it the fourth-best performing stock on the S&P/NZX All Capital Index. NZME